Patent details
EP2540745 Title: FULLY HUMANIZED ANTI-HER2 ANTIBODY, PREPARATION METHOD AND USE THEREOF
Basic Information
- Publication number:
- EP2540745
- PCT Application Number:
- PCT/CN/2010/000511
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP108463241
- PCT Publication Number:
- WO/2011/103700
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- Not available
- English Title of Invention:
- FULLY HUMANIZED ANTI-HER2 ANTIBODY, PREPARATION METHOD AND USE THEREOF
- French Title of Invention:
- ANTICORPS ANTI-HER2 COMPLÈTEMENT HUMANISÉ, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
- German Title of Invention:
- VOLLSTÄNDIG HUMANISIERTER ANTI-HER2-ANTIKÖRPER, HERSTELLUNGSVERFAHREN UND VERWENDUNG
- SPC Number:
Dates
- Filing date:
- 16/04/2010
- Grant date:
- 30/09/2015
- EP Publication Date:
- 30/09/2015
- PCT Publication Date:
- 01/09/2011
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 02/01/2013
- EP B1 Publication Date:
- 30/09/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 16/04/2016
- Expiration date:
- 16/04/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 16/04/2010
- Name:
- Shanghai Biomabs Pharmaceuticals Co. Ltd
- Address:
- No. 301, Libing Road, Pudong District Shanghai 201203, China (CN)
Inventor
1
- Name:
- LI Chuan
- Address:
- China (CN)
2
- Name:
- TONG Xin
- Address:
- China (CN)
3
- Name:
- KAN Ying
- Address:
- China (CN)
Priority
- Priority Number:
- 201010125241
- Priority Date:
- 25/02/2010
- Priority Country:
- China (CN)
Classification
- Main IPC Class:
- C07K 16/28;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|